Skip to main content

Can you take Xyrem while pregnant?

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 26, 2024.

Official answer

by Drugs.com

Xyrem is not recommended during pregnancy because it readily crosses the placenta. Xyrem is a central nervous system (CNS) depressant that slows down brain activity, which may be detrimental to a developing baby. Xyrem should not be given to pregnant women unless the perceived benefits far outweigh the risks.

The effects of Xyrem have not been formally studied in labor or delivery and few pregnant women have received Xyrem (sodium oxybate). This means data on its effects during pregnancy are limited.

  • In women given Xyrem during childbirth, newborns were very sleepy, causing a slight decrease in Apgar scores, although cardiovascular and respiratory measures were stable. The frequency of uterine contractions also fell 20 minutes after the injection.
  • Research has shown that Xyrem quickly crosses from the mother’s bloodstream into the placenta, and can be detected in a newborn's bloodstream. The effects of this on an infant's subsequent growth, development, and maturation are unknown.
  • A small number of pregnant women have been exposed to Xyrem during the first trimester. There appeared to be a possible increased risk in the number of spontaneous abortions. Babies of women exposed in the second or third trimester did not appear to suffer any birth defects or toxicity; however, very few women have been studied.

Although animal studies have not shown an increased risk of birth defects, there was an increased number of stillbirths and post-birth deaths in baby rats given sodium oxybate (Xyrem).

  • Sodium oxybate given to pregnant rats during organogenesis did not appear to cause developmental toxicity or birth defects in baby rats. Organogenesis in humans occurs anywhere between the third to eighth week of gestation and is the stage during which three germ layers of the embryo form into the major organs of the body system.
  • Sodium oxybate that was administered to rats throughout pregnancy and lactation resulted in an increased number of stillbirths, an increase in the number of deaths in the baby rats once born, and decreased growth rates in those baby rats that survived.

The FDA has not assigned a pregnancy category to Xyrem.

Related questions

References

Read next

How does Xyrem work for narcolepsy?

Xyrem's mechanism of action for narcolepsy is thought to involve binding to GABAB and GHB receptors which enhances delta wave activity, improving the quality and quantity of deep sleep; however, the exact way it works is unknown. Continue reading

Is Xyrem a controlled substance / narcotic drug of abuse?

Yes, Xyrem is a controlled substance, and has a high potential to be abused. Xyrem contains sodium oxybate, also known as GHB, which is a known street drug of abuse. Xyrem is not a narcotic, the active ingredient sodium oxybate, is a central nervous system depressant. Continue reading

Does Xyrem cause weight gain or loss?

Xyrem (sodium oxybate), which is used to treat cataplexy or excessive daytime sleepiness (EDS) in patients 7 years of age and older with narcolepsy, can cause weight loss. Weight loss is reported to be an adverse reaction associated with Xyrem treatment, but it is also seen as a beneficial effect of the drug because narcolepsy is linked to weight gain and obesity. Continue reading

Related medical questions

Drug information

Related support groups